Supernus Pharmaceuticals
SUPN
#4336
Rank
C$2.78 B
Marketcap
$50.52
Share price
1.12%
Change (1 day)
33.02%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.46 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.47 B-57.35%
2022-12-31C$1.10 B-0.47%
2021-12-31C$1.11 B14.97%
2020-12-31C$0.96 B31.22%
2019-12-31C$0.73 B3.2%
2018-12-31C$0.71 B262.2%
2017-12-31C$0.19 B24.66%
2016-12-31C$0.15 B13.43%
2015-12-31C$0.13 B25.18%
2014-12-31C$0.11 B35.11%
2013-12-31C$82.53 M127.89%
2012-12-31C$36.21 M-19.61%
2011-12-31C$45.04 M-50.65%
2010-12-31C$91.29 M0.82%
2009-12-31C$90.54 M-11.22%
2008-12-31C$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.42 B 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$85.47 B 18,164.35%๐Ÿ‡บ๐Ÿ‡ธ USA
C$106.65 B 22,689.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$47.87 B 10,130.34%๐Ÿ‡บ๐Ÿ‡ธ USA
C$150.80 B 32,124.31%๐Ÿ‡บ๐Ÿ‡ธ USA